Skip to main content

Harrison.ai

Category: AI in Healthcare

An AI-powered healthcare company that develops and deploys clinical-grade diagnostic solutions to improve the standard of care by assisting clinicians. Harrison.ai was founded in 2018. The company is led by Dr Aengus Tran. Based in Sydney, Australia (Headquarters); Global offices including London, UK and Boston, USA.. Team size: Over 350. Total funding raised: AUD $158 million. Latest round: Series B. Key investors include Horizons Ventures, Blackbird Ventures, Skip Capital, I-MED Radiology Network.

Founded
2018
Headquarters
Sydney, Australia (Headquarters); Global offices including London, UK and Boston, USA.
Team size
Over 350
Total funding
AUD $158 million

Value proposition

To make healthcare more equitable and accessible by scaling the global capacity of clinicians through AI-powered tools that enhance diagnostic accuracy and efficiency.

Products and solutions

Annalise.ai: A comprehensive AI solution for radiologists, capable of detecting up to 124 findings on chest X-rays and 130 findings on brain CT scans., Franklin.ai: An AI-powered platform for pathologists, with an initial focus on automating the analysis of prostate biopsies to identify and classify cancer.

Unique value

A joint venture model where Harrison.ai partners with major healthcare providers (like I-MED Radiology and Sonic Healthcare) to co-develop and validate AI solutions using vast, real-world clinical datasets.

Target customer

Hospitals, radiology clinics, pathology labs, and other healthcare providers.

Industries served

Healthcare, Radiology, Pathology

Technology advantage

Access to large, diverse, and proprietary clinical datasets through its joint ventures, enabling the development of robust and clinically-validated AI models. This model also provides an embedded distribution channel and immediate clinical feedback.

How they differentiate

Harrison.ai's solutions, particularly Annalise CXR, cover a significantly larger number of clinical findings (124) compared to competitors. Its joint-venture model with clinical partners provides a unique advantage in data access, rapid validation, and commercial rollout.

Main competitors

Aidoc, Viz.ai, Paige.AI

Key partnerships

I-MED Radiology Network (for Annalise.ai), Sonic Healthcare (for Franklin.ai)

Notable customers

I-MED Radiology Network, RadNet (USA), Major hospitals and imaging centers across Australia, Europe, and Asia.

Major milestones

Raised AUD $129 million in a 2021 Series B round, one of Australia's largest for a healthcare AI company., Secured regulatory clearances for Annalise.ai in over 40 countries, including FDA clearance (USA), CE mark (Europe), and TGA approval (Australia)., Formed a landmark partnership with Sonic Healthcare to launch Franklin.ai for pathology., Announced major US expansion and partnership with RadNet, a leading US outpatient imaging provider.

Growth metrics

Deployed in over 500 healthcare facilities, assisting with the treatment of millions of patients annually. The company has reported tripling its contracted annual recurring revenue (ARR) each year since monetization began.

Market positioning

A well-funded, rapidly scaling leader in the multi-finding radiology AI space, with a strong global footprint and a strategic focus on expanding into the US market.

Geographic focus

Global, with an established presence in Australia, New Zealand, Europe, and Asia, and a major expansion initiative into the United States.

Patents and IP

Information not publicly disclosed. The company protects its intellectual property through a combination of trade secrets and patents.

About Dr Aengus Tran

Dr. Aengus Tran, a medical doctor turned entrepreneur, co-founded Harrison.ai in 2018. He leads the company's mission to develop AI-powered diagnostic solutions, aiming to improve healthcare accessibility and efficiency globally. His work focuses on creating scalable AI tools for radiology and pathology to support clinicians and enhance patient outcomes.

Official website: